Brivekimig (F-027300252, SAR-442970) is a bispecific nanobody targeting TNF/OX40L. Brivekimig is applicable to research related to hidradenitis suppurativa.
Molecular Weight:
(66.21 kDa)
Purity:
98
CAS Number:
[2834733-45-6]
Target:
TNF Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted